Warren J. Strittmatter, MD
Affiliations: | Neurology | Duke University, Durham, NC |
Area:
Alzheimer's diseaseWebsite:
http://www.dukehealth.org/physicians/warren_j_strittmatterGoogle:
"Warren Strittmatter"Bio:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=130
Cross-listing: Neurotree
Parents
Sign in to add mentorStanley Appel | grad student | (Neurotree) | |
Robert J. Lefkowitz | post-doc | 1978-1978 | Duke (Neurotree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Popiel HA, Takeuchi T, Burke JR, et al. (2013) Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseases. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 440-6 |
Strittmatter WJ. (2013) Bathing the brain. The Journal of Clinical Investigation. 123: 1013-5 |
Strittmatter WJ. (2012) Alzheimer’s disease: the new promise. The Journal of Clinical Investigation. 122: 1191 |
Strittmatter WJ. (2012) Medicine. Old drug, new hope for Alzheimer's disease. Science (New York, N.Y.). 335: 1447-8 |
Swaminathan M, Nicoara A, Phillips-Bute BG, et al. (2011) Utility of a simple algorithm to grade diastolic dysfunction and predict outcome after coronary artery bypass graft surgery. The Annals of Thoracic Surgery. 91: 1844-50 |
Heinzen EL, Need AC, Hayden KM, et al. (2010) Genome-wide scan of copy number variation in late-onset Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 19: 69-77 |
Need AC, Ge D, Weale ME, et al. (2009) A genome-wide investigation of SNPs and CNVs in schizophrenia. Plos Genetics. 5: e1000373 |
Lai TS, Liu Y, Tucker T, et al. (2008) Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries. Chemistry & Biology. 15: 969-78 |
Weinberg JB, Volkheimer AD, Mihovilovic M, et al. (2008) Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia. Leukemia. 22: 2184-92 |
Hamuro L, Zhang G, Tucker TJ, et al. (2007) Optimization of a polyglutamine aggregation inhibitor peptide (QBP1) using a thioflavin T fluorescence assay. Assay and Drug Development Technologies. 5: 629-36 |